FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.67B
AUM Growth
+$293M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1
+$29.1M
2
+$24.4M
3
+$18.2M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$16.6M
5
BBIO icon
BridgeBio Pharma
BBIO
+$14.1M

Top Sells

1
+$11.6M
2
+$11.6M
3
+$7.79M
4
RNA icon
Avidity Biosciences
RNA
+$7.67M
5
REPL icon
Replimune Group
REPL
+$6.97M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
– –
-610,000
52
– –
-1,352,199
53
– –
-17,025
1 2
3